Who invested in Vivet Therapeutics?
Vivet Therapeutics's investors include U.S. Venture Partners, Novartis Venture Fund, Eurazeo, Pfizer and KurmaPartners, and 1 more on record.

France · Funded startup
Funding summaryUpdated 26 Oct 2026
$96Mraised across 3 rounds since 2017, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From Vivet Therapeutics's own website: 1 founder.
AdvisersGloria Gonzalez Aseguinolaza
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Vivet Therapeutics's investors include U.S. Venture Partners, Novartis Venture Fund, Eurazeo, Pfizer and KurmaPartners, and 1 more on record.
Vivet Therapeutics has raised $96M across 3 rounds since 2017.
Vivet Therapeutics's most recent round was a Grant of $5.3M in Feb 2024.
Vivet Therapeutics's largest round on record is $51M (Undisclosed round), in Mar 2019.
Vivet Therapeutics's first round on record, in May 2017, was backed by Novartis Venture Fund and Columbus Venture Partners/ Roche Venture.
Vivet Therapeutics's latest named round is a Grant, in Feb 2024.
Vivet Therapeutics is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.